United States · FDA National Drug Code directory
XIFAXAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65649-301_b2e9bb84-e97e-4e7e-8a23-425418b4374d
- Product NDC
- 65649-301
- Form
- TABLET
- Composition / generic term
- rifaximin
- Labeler
- Salix Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20040725
- Source listing expiry
- 20271231
Source-listed ingredients
- RIFAXIMIN — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (65649-301-03) · 65649-301-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →